Menu
Pfizer recently notified some 340B hospital covered entities that they could lose their approved one contract pharmacy exemption registered with industry vendor 340B ESP as of Nov. 1.

Pfizer Tightens 340B Contract Pharmacy Restrictions for Hospitals It Believes are Not in Compliance; Novartis, Sobi Exempt New States

Shannon Young, Associate Editor/Senior Writer 340B Report Views
A major drugmaker recently announced changes to how—and where—certain 340B hospitals can receive shipments of 340B-priced drugs, while two other [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

Drug Industry Files New Lawsuits Against 340B Contract Pharmacy Laws in Rhode Island, Maine, Oregon

Hospitals, HRSA Agree to Voluntarily Dismiss Appeal Over J&J 340B Audits

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Quick verification required before signup

Site Footer Live